26517679 | Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells. | Oncotarget | 2015 Nov 24 | Oh SJ | doi: 10.18632/oncotarget.5434. |
19737969 | Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. | Mol Cancer Res | 2009 Sep | Lin E | doi: 10.1158/1541-7786.MCR-08-0522 |
27507192 | Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study. | J Thorac Oncol | 2017 Feb | Zhang Z | doi: 10.1016/j.jtho.2016.07.027 |
24633422 | Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target. | World J Surg | 2014 Jun | Demeure MJ | doi: 10.1007/s00268-014-2485-3. |
20183914 | Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene. | Ann Surg Oncol | 2010 Mar | Takahashi T | doi: 10.1245/s10434-009-0808-7. |
18594010 | EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. | Clin Cancer Res | 2008 Jul 1 | Koivunen JP | doi: 10.1158/1078-0432.CCR-08-0168. |
26704814 | Second Primary Lung Adenocarcinoma Harboring EML4-ALK After Surgically Resected EGFR Positive Lung Adenocarcinoma. | Clin Lung Cancer | 2016 Mar | Takenaka T | doi: 10.1016/j.cllc.2015.11.005 |
19147828 | EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. | Am J Pathol | 2009 Feb | Martelli MP | doi: 10.2353/ajpath.2009.080755 |
18927303 | Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. | Clin Cancer Res | 2008 Oct 15 | Takeuchi K | doi: 10.1158/1078-0432.CCR-08-1018. |
21356191 | Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer. | Cancer Genet | 2011 Jan | Sanders HR | doi: 10.1016/j.cancergencyto.2010.08.024. |
20578368 | [Discovery of EML4-ALK, a new gene responsible for lung cancer, and the development of molecular targeted therapy]. | Nihon Naika Gakkai Zasshi | 2010 Apr 10 | Mano H | - |
22056890 | Successful long-term treatment with pemetrexed of NSCLC associated with EML4-ALK and low thymidylate synthase expression. | Clin Lung Cancer | 2012 Mar | Takeda M | doi: 10.1016/j.cllc.2011.09.003 |
26755435 | Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. | Cell Mol Life Sci | 2016 Mar | Bayliss R | doi: 10.1007/s00018-015-2117-6 |
23154565 | First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component. | J Thorac Oncol | 2012 Dec | Toyokawa G | doi: 10.1097/JTO.0b013e3182762bcb. |
22722791 | A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer. | J Thorac Oncol | 2012 May | Sakai K | doi: 10.1097/JTO.0b013e31824c7f7a. |
24952482 | Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells. | Oncotarget | 2014 Jul 15 | Tanimoto A | - |
23169500 | Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer. | J Clin Oncol | 2013 Jan 1 | Tamiya A | doi: 10.1200/JCO.2012.43.3730 |
25721120 | Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer. | Oncologist | 2015 Mar | Pekar-Zlotin M | doi: 10.1634/theoncologist.2014-0389 |
22706607 | A novel EML4-ALK variant: exon 6 of EML4 fused to exon 19 of ALK. | J Thorac Oncol | 2012 Jul | Penzel R | doi: 10.1097/JTO.0b013e3182598af3. |
18593892 | Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. | Cancer Res | 2008 Jul 1 | Choi YL | doi: 10.1158/0008-5472.CAN-07-6158. |
26964537 | Ground-glass nodule in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK)-positive lung cancer: a case report. | World J Surg Oncol | 2016 Mar 10 | Owada Y | doi: 10.1186/s12957-016-0841-5. |
28039177 | Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer. | Ann Oncol | 2017 Apr 1 | Woo CG | doi: 10.1093/annonc/mdw693. |
29363116 | EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer. | Int J Cancer | 2018 Jun 15 | Christopoulos P | doi: 10.1002/ijc.31275 |
30236141 | Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. | Mol Cancer | 2018 Sep 20 | Tan S | doi: 10.1186/s12943-018-0887-9. |